The overall ratings of four capital markets stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
This week, Investment Technology Group, Inc. () falls to a D (“sell”), worse than last week’s grade of C (“hold”). Investment Technology Group is an agency brokerage and financial technology firm that partners with asset managers globally to provide innovative solutions spanning the investment continuum. In Portfolio Grader’s specific subcategories of Earnings Growth, Cash Flow and Sales Growth, ITG also gets an F. The stock’s trailing PE Ratio is 51.00. .
Best Building Product Stocks To Watch Right Now: Boston Scientific Corp (BSX)
Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. During the year ended December 31, 2011, its products were offered for sale by seven core businesses: Interventional Cardiology, CRM, Endoscopy, Peripheral Interventions, Urology/Women��s Health, Neuromodulation, and Electrophysiology. In January 2011, it completed the acquisition of Intelect Medical, Inc. In January 2011, it completed the acquisition of Sadra Medical, Inc. In March 2011, the Company completed the acquisition of Atritech, Inc. In February 2011, it announced the acquisitions of S.I. Therapies and ReVascular Therapeutics, Inc. In January 2011, the Company sold its Neurovascular business to Stryker Corporation. In June 2012, the Company acquired Cameron Health, Inc. of San Clemente, California and, as a result, added to its product portfolio subcutaneous implantable cardioverter defibrillator, called the S-ICD System.
Interventional Cardiology
The Company offers coronary stent product. Coronary stents are tiny, mesh tubes used in the treatment of coronary artery disease, which are implanted in patients to prop open arteries and facilitate blood flow to and from the heart. The Company offers a two-drug platform strategy with its paclitaxel-eluting and everolimus-eluting stent system offerings, and it offers a range of stent sizes. The Company markets its next-generation internally-developed and self-manufactured PROMUS Element stent system in the United States, its Europe/Middle East/Africa (EMEA) region and certain Inter-Continental countries, including China and India. It markets the PROMUS everolimus-eluting stent system, supplied to the Company by Abbott Laboratories, in Japan. It also markets its TAXUS paclitaxel-eluting stent line, including its third-generation TAXUS Element paclitaxel-eluting stent system in the U.nited States, Japan, EMEA and certain Inter-Continental countries.
The Compa! ny markets a line of products used to treat patients with atherosclerosis, a principal cause of coronary artery obstructive disease. Its product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices, and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA). The Company markets a family of intraluminal catheter-directed ultrasound imaging catheters and systems for use in coronary arteries and heart chambers, as well as certain peripheral vessels. The iLab Ultrasound Imaging System continues as its flagship console and is compatible with its line of imaging catheters. The system is designed to enhance the diagnosis and treatment of blocked vessels and heart disorders. Sadra is developing a repositionable and retrievable device for transcatheter aortic valve replacement (TAVR) to treat patients with severe aortic stenosis. The Lotus Valve System consists of a stent-mounted tissue valve prosthesis and catheter delivery system for guidance and placement of the valve. Atritech has developed a device designed to close the left atrial appendage in patients with atrial fibrillation who are at risk for ischemic stroke. The WATCHMAN Left Atrial Appendage Closure Technology, developed by Atritech, is the first device proven in a randomized clinical trial to offer an alternative to anticoagulant drugs, and is approved for use in CE Mark countries.
Cardiac Rhythm Management
The Company develops, manufactures and markets a variety of implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, including Implantable cardioverter defibrillator (ICD) systems used to detect and treat abnormally fast heart rhythms (tachycardia) that could result in sudden cardiac death, including implantable cardiac resynchronization therapy defibrillator (CRT-D) systems used to treat heart failure, and implantable pacemaker systems used to manage slow or irregular heart rhyth! ms (brady! cardia), including implantable cardiac resynchronization therapy pacemaker (CRT-P) systems used to treat heart failure. Its product offerings include its COGNIS cardiac resynchronization therapy defibrillator (CRT-D), its TELIGEN ICD systems and its ALTRUA family of pacemaker systems. During 2011, it began the United States launch of its next-generation line of defibrillators, INCEPTA, ENERGEN and PUNCTUA.
Endoscopy
The Company markets a range of products to diagnose, treat and ease a variety of digestive diseases, including those affecting the esophagus, stomach, liver, pancreas, duodenum, and colon. Common disease states include esophagitis, portal hypertension, peptic ulcers as well as esophageal, biliary, pancreatic and colonic cancer. The Company offers the Radial Jaw 4 Single-Use Biopsy Forceps, which are designed to enable collection of large high-quality tissue specimens without the need to use large channel therapeutic endoscopes. Its exclusive line of RX Biliary System devices are designed to provide greater access and control for physicians to diagnose and treat challenging conditions of the bile ducts, such as removing gallstones, opening obstructed bile ducts and obtaining biopsies in suspected tumors. The Company also markets the Spyglass Direct Visualization System for direct imaging of the pancreatico-biliary system. The Spyglass System is a single-operator cholangioscopy device that offers clinicians a direct visualization of the pancreatico-biliary system and includes supporting devices for tissue acquisition, stone management and lithotripsy. Its products also include the WallFlex family of stents, in particular, the WallFlex Biliary line and WallFlex Esophageal line; and in 2011, the Company launched its Advanix Biliary Plastic Stent System and the Expect Endoscopic Ultrasound Aspiration Needle in the United States and certain international markets. Its Resolution Clip Device is an endoscopic mechanical clip designed to treat gastrointestinal bleeding.
T! he Company markets devices to diagnose, treat and ease pulmonary disease systems within the airway and lungs. Its products are designed to help perform biopsies, retrieve foreign bodies from the airway, open narrowings of an airway, stop internal bleeding, and ease symptoms of some types of airway cancers. Its product line includes pulmonary biopsy forceps, transbronchial aspiration needles, cytology brushes and tracheobronchial stents used to dilate narrowed airway passages or for tumor management. Asthmatx, Inc. designs, manufactures and markets a less-invasive, catheter-based bronchial thermoplasty procedure for the treatment of severe persistent asthma. The Alair Bronchial Thermoplasty System, developed by Asthmatx, has both CE Mark and Food and Drug Administration (FDA) approval and is the first device-based asthma treatment approved by the FDA.
Peripheral Interventions
The Company sells various products designed to treat patients with peripheral disease, including a line of medical devices used in percutaneous transluminal angioplasty and peripheral vascular stenting. Its peripheral product offerings include stents, balloon catheters, wires, peripheral embolization devices and vena cava filters. In 2010 and 2011, it launched several of its products internationally, including the EPIC self-expanding nitinol stent system in certain international markets, and the Carotid WALLSTENT stent system in Japan. The Company launched three new peripheral angioplasty balloons in 2011, including its next-generation Mustang percutaneous transluminal angioplasty (PTA) balloon, its Coyote balloon catheter, a highly deliverable and ultra-low profile balloon dilatation catheter designed for a range of peripheral angioplasty procedures and its Charger PTA Balloon Catheter, a 0.035 inch percutaneous transluminal angioplasty balloon catheter designed for post-stent dilatation, as well as conventional balloon angioplasty to open blocked peripheral arteries. The Company has commenced a limited ma! rket rele! ase of its OFFROAD re-entry catheter system in certain international markets, and in February 2012, it launched its TRUEPATH intraluminal CTO device in the United States.
The Company sells products designed to treat patients with non-vascular disease. Its non-vascular suite of products include biliary stents, drainage catheters and micro-puncture sets designed to treat, diagnose and ease various forms of benign and malignant tumors. The Company continues to market its extensive line of Interventional Oncology product solutions, including the Renegade HI-FLO Fathom microcatheter and guidewire system and Interlock - 35 Fibered IDC Occlusion System for peripheral embolization. The Company��s FilterWire EZ Embolic Protection System is a filter designed to capture embolic material that may become dislodged during a procedure, which could otherwise travel into the microvasculature where it could cause a heart attack or stroke. It is commercially available in the United States, its EMEA region and certain Inter-Continental countries for multiple indications, including the treatment of disease in peripheral, coronary and carotid vessels. It is also available in the United States for the treatment of saphenous vein grafts and carotid artery stenting procedures.
Urology/Women��s Health
The Company��s Urology/Women��s Health division develops, manufactures and sells devices to treat various urological and gynecological disorders. The Company sells a variety of products designed to treat patients with urinary stone disease, stress urinary incontinence, pelvic organ prolapse and excessive uterine bleeding. The Company offers a line of stone management products, including ureteral stents, wires, lithotripsy devices, stone retrieval devices, sheaths, balloons and catheters.
The Company markets a range of devices for the treatment of conditions, such as female urinary incontinence, pelvic floor reconstruction (rebuilding of the anatomy to its original state), and ! menorrhag! ia (excessive menstrual bleeding). It offers a breadth of mid-urethral sling products, sling materials, graft materials, pelvic floor reconstruction kits, and suturing devices. The Company markets its Genesys Hydro ThermAblator (HTA) system, a next-generation endometrial ablation system designed to ablate the endometrial lining of the uterus in premenopausal women with menorrhagia. The Genesys HTA System features a smaller and lighter console, simplified set-up requirements, and an enhanced graphic user interface and is designed to improve operating performance.
Neuromodulation
The Company within its Neuromodulation business markets the Precision Spinal Cord Stimulation (SCS) system, used for the management of chronic pain. In 2011, the Company launched its Clik Anchor for its Precision Plus SCS System, a rechargeable SCS device for chronic pain management. During 2011, it received FDA approval for and launched the Infinion 16 Percutaneous Lead, a 16-contact percutaneous lead. The Company also markets the Linear 3-4 and Linear 3-6 Percutaneous Leads for use with its SCS systems, which are designed to provide physicians more treatment options for their chronic pain patients. Intelect Medical, Inc. is a development-stage company developing advanced visualization and programming for the Vercise system.
Electrophysiology
The Company within its Electrophysiology business develops less-invasive medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart. Included in its product offerings are radio frequency (RF) generators, steerable RF ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories. Its products include the Blazer and Blazer Prime line of temperature ablation catheters, designed to deliver enhanced performance, responsiveness, and durability. Its cooled ablation portfolio includes the closed-loop irrigated catheter on the market, the Chilli II cooled! ablation! catheter, and the newly launched Blazer Open-Irrigated ablation catheter with a Total Tip Cooling Design.
The Company competes with Abbott Laboratories, Medtronic, Inc., St. Jude Medical, Inc. and Johnson & Johnson.
Advisors' Opinion:- [By Vera Yuan]
��Medical device manufacturer Boston Scientific Corp. (BSX) reported solid earnings for the first quarter but investors focused on near-term headwinds in the cardiac-rhythm management business. The company also announced a delay in potential approval for its Watchman��s heart device. Given the breadth of the company��s pipeline, potential for margin upside, and attractive valuation, we continue to like the outlook for the shares going forward.From Diamond Hill Capital (Trades, Portfolio)'s Select Fund Second Quarter 2014 Commentary.Also check out: Diamond Hill Capital Undervalued Stocks Diamond Hill Capital Top Growth Companies Diamond Hill Capital High Yield stocks, and Stocks that Diamond Hill Capital keeps buying Currently 0.00/512345
Rating: 0.0/5 (0 votes)
Best Building Product Stocks To Watch Right Now: Clicksoftware Technologies Ltd (CKSW)
ClickSoftware Technologies Ltd. (ClickSoftware), incorporated in 1979, is a provider of software products and solutions for workforce management and optimization for the service sector. The Company derives revenues from the licensing of its software products and the provision of consulting and support services. It also generates revenues from Cloud-based solutions. under software as a service (SaaS) model. ClickSoftware��s solutions are grouped into four main suites which together comprise its Service Optimization Suite: Field Service Daily Suite, Mobility Suite, Roster (Shift Planning) Suite and Forecasting and Planning Suite. Additionally, it offers variations of its products for certain vertical markets, including Mid-Market Package - Installation, Maintenance and Repair Services (ClickIMRS) and Service Tycoon. Its products include: ClickSchedule, ClickAnalyze, ClickLocate, ClickContact, ClickRoster, ClickPlan, and ClickForecast. In March 2014, the Company acquired Xora Inc., a cloud-based mobile workforce management.
Field Service Daily Suite covers automatic decision making and optimization support to manage field service operations: commencing from appointment booking and scheduling during the period around the day of service, followed by real time scheduling and optimization during the day of service and culminating with reports and business metrics analytics after the day of service. Roster (Shift Planning) Suite covers shift planning needs for both the manager, as well as the employee to optimize the balance between staffing levels needed for serving customers and managing labor costs, and employee preferences. This suite is offered in several configurations for different industry verticals ranging from police forces to contact centers, and more. Mobility Suite covers the needs of the mobile individual and back-office staff for field data communication, such as sending jobs from the back office to the person��s hand-held device, and the person��s ability to accept/decline the ! job, report on progress and job completion, as well as capturing customers�� signatures, or sending the person��s own time sheet to the back office. Geography support, such as travel guidance and information about underground equipment are also covered.
ClickSchedule optimizes service scheduling and routing to improve workforce productivity by balancing customer, service and asset resources, and organizational preferences, including contractual commitments, priority, drive time, skills, and service and asset resources availability. ClickAnalyze provides reporting, monitoring and service business analytics for workforce performance measurement and strategic decision support. It enables analysis of key performance indicators, including resource productivity, operational costs, and responsiveness to customers.
ClickLocate (LBS) captures the location information of a field service engineer and/or his or her vehicle obtained via GPS or other technology and integrates it with ClickSchedule for use in optimized scheduling. LBS then enables service organizations to improve their service operations by allowing them to make decisions and take actions based on location information, including near real-time engineer locations. ClickContact is a customer interaction management solution that enables self-service appointment booking, order updating, automatic customer notifications and customer satisfaction surveying. From scheduling the initial appointment through enabling a post-service follow-up survey, ClickContact provides customer interaction management throughout the service lifecycle.
ClickRoster provides interactive and automated workforce shift planning based on forecasted workload by quantities and skill requirements, rules and regulations, working contracts, engineer skills, calendar and preferences. ClickPlan provides interactive and automated workforce planning for staffing and deployment of the field workforce based on forecasted workload. It is designed ! to enable! service organizations to resolve workforce shortages and surpluses weeks and months in advance. ClickForecast provides field service workload forecasting to enable companies to project workforce capacity. It enables service managers, marketing, and sales to determine the demand levels of customers, and to create multiple forecast scenarios, each with different business assumptions. (ClickIMRS) is a pre-configured package that has been tailored to the needs of small and mid-sized companies. ClickIMRS features pre-configured scheduling and reporting that reduces the expense, time and effort required to custom-design and program schedules and reports. In addition, the ready-to-use reports provide insight into service operations and streamline decision-making on the part of both service management and dispatchers.
ClickSoftware Cloud Services include two Web-based offerings of its complete Service Optimization Suite. ClickCloud offers medium and market enterprise customers an alternative to on-premises deployment of the Service Optimization Suite. ClickCloud also enables a hybrid information technology (IT) model, which is a solution comprised of a mix of Cloud and on-premises deployment ClickExpress offers the customers to be up and running within a relatively short period of time, with its products.
Advisors' Opinion:- [By Evan Niu, CFA]
What: Shares of ClickSoftware (NASDAQ: CKSW ) have plunged today by as much as 13% after the company warned that second-quarter results would fall short of expectations.
- [By Sean Williams]
Optimize your buying
Software companies these days are being judged not just by how many new contracts they gained during the current quarter, but by how well they're prepared to deal with the transition to cloud platforms. Supply-chain and workforce-optimization software developer ClickSoftware Technologies (NASDAQ: CKSW ) looks well poised to take advantage of these trends and has no business, in my opinion, being anywhere near a 52-week low.
Top Managed Healthcare Companies To Invest In Right Now: Entest Biomedical Inc (ENTB)
Entest BioMedical, Inc. (Entest), incorporated on September 24, 2008, is a development-stage company. During the fiscal year ended August 31, 2012, the Company��s business consists of the development and commercialization of immunotherapeutic therapies for the veterinary market, as well as the acquisition and operation of veterinary hospitals. The Company is focusing its research and development efforts toward the development and commercialization of the ImenVax family of canine cancer vaccines. ImenVax I is a therapeutic for canine cancer, which involves isolating tumor cells from the patient and then placing the cells into a cell implant device that is inserted subcutaneously into the patient. ImenVax II, which utilizes cell lines for sustained release of immunologically relevant cytokines for maximum anti-tumor immune responses.
ImenVax
The Company is conducting a ten dog safety study to Evaluate ImenVax I for the Treatment of Canine Oral Melanoma. As of May 17, 2012 three dogs suffering from oral melanoma have been administered the therapy with no dog suffering any material adverse reaction.
ImenVax II
The Company intends to include adjuvant cytokine along with tumor cells into the implantation device. The adjuvants can be added through cytokine expressing cell line.
ImenVax III
ImenVax III is intended to function by harnessing the ability of placental extracts to combat canine cancers. ImenVax III is intended to treat existing tumors through stimulation of immune responses to kill tumor cells directly; indirectly kill tumor cells by cutting off the tumor blood supply, and block the ability of the tumor to suppress the immune system.
ENT-576
ENT-57 is a therapy being developed by the Company for the treatment of Chronic Obstructive Pulmonary Disease (COPD), such therapy consists of extracting a therapeutic number of cells from a tissue containing in part a stem cell population; processing sai! d population of cells derived from said tissue so as to concentrate said stem cell population; systemic re-administration of said cell population into the same patient, and exposing the patient lung to a sufficient intensity and frequency of laser irradiation necessary to augment therapeutic activity of said cells in said patient suffering from COPD. A therapeutic intervention in COPD would require addressing the issues of inflammation and regeneration.
Advisors' Opinion:- [By Peter Graham]
Small cap mining stocks US Tungsten Corp (OTCMKTS: USTU) and LKA Gold Inc (OTCMKTS: LKAI) along with biotech Entest BioMedical Inc (OTCMKTS: ENTB) have been getting some attention lately in various investment newsletters with at least one of these stocks being the subject of paid promotions while another could soon be the subject of an investor relations campaign. But will any of these small cap stocks be winners for investors or traders? Here is a quick reality check:
Best Building Product Stocks To Watch Right Now: Xyratex Ltd.(XRTX)
Xyratex Ltd provides modular solutions for the enterprise data storage industry and hard disk drive (HDD) capital equipment for the HDD industry. It offers enterprise data storage solutions that include storage enclosures, which provide a common technology platform that reduces qualification time for original equipment manufacturer (OEM) customers and includes management interface software, standardized across enclosures, and provides easy integration as new platforms; integrated application platforms that comprise embedded storage platforms, which incorporate embedded server modules into its storage enclosures; and HPC Solutions that consolidate controllers, storage enclosures, application platforms, operating system, data protection, Lustre File System, and management software into a optimized scale-out storage platform that can be deployed in hours rather than weeks. The company also designs and manufactures a range of process test systems, which incorporate mechanical and electronic hardware, and firmware for controlling the HDD operating environment during the formatting of the disk drive. In addition, it provides automated solutions comprising substrate and media inspection systems; servo track writers and related subassemblies; and head testing systems that test and process HDD components throughout the manufacturing process. The company markets and sells its products primarily to OEMs and disk drive manufacturers, as well as to other companies in North America, Asia, and Europe. Xyratex Ltd was founded in 1966 and is headquartered in Havant, the United Kingdom.
Advisors' Opinion:- [By Jonathan Fishman]
Two weeks ago an SA contributor, Kingsley Park Capital, pointed out that shares of Xyratex (XRTX) have a 70% upside. I suggest KPC is being conservative. I think its opinion is priceless, but I would like to offer my financial model to support this thesis and show that the moment the market realizes what's going on, XRTX should be worth $20-$30 a share a year or so from now. Let's get started.
- [By Lisa Levin]
Xyratex (NASDAQ: XRTX) shares moved up 26.89% to $13.26. The volume of Xyratex shares traded was 11058% higher than normal. Seagate Technology Plc (NASDAQ: STX) announced its plans to buy Xyratex for around $374 million in cash.
- [By Patricio Kehoe]
According to GuruFocus Real Time Picks, on March 7, Mario Gabelli (Trades, Portfolio), the chairman and chief executive officer of GAMCO Investors Inc. added Xyratex Ltd. (XRTX) at an average price of $13.17 and currently holds 742,642 shares of the stock, worth 0.05% of his portfolio.
- [By Rick Aristotle Munarriz]
Bloomberg via Getty Images You can never know in advance all the news that will move the market in a given week, but some things you can see coming. From a parade of bankers' earnings to a pizza giant rolling out a new crust, here are some of the things that will help shape the week ahead on Wall Street. Monday -- X Marks the Spot: Data storage is a big part of businesses in the modern age; companies have massive amounts of information to manage and keep secure. Xyratex (XRTX) may not be a household name, but it is well-known to corporate IT departments seeking enterprise data storage solutions. Xyratex reports on Monday afternoon. It's seen better days, and analysts predict it will report a sharp drop in revenue. However, Xyratex has been able to beat Wall Street's profit targets with ease over the past four quarters. Tuesday -- Big Banking's Big Close Up: It's going to be a roll call of the "too big to fail" banking behemoths as they step up for their quarterly results. Wells Fargo (WFC) and JPMorgan Chase (JPM) kick things off on Tuesday. That will be followed by Bank of America (BAC) on Wednesday. Citigroup (C) and Goldman Sachs (GS) step up on Thursday. These are interesting times for the financial services providers. Interest rates are starting to move higher, and that may get in the way of demand for mortgages, but it will also help improve the chances that customers open and fund savings and checking accounts. Wednesday -- Tracking Trains: Railroads may seem like yesterday's mode of transportation, but rail remains a viable way to get goods moving across the country. CSX (CSX) reports on Wednesday. The provider of rail, intermodal, and rail-to-truck transload services and solutions has been shipping goods for 185 years. It offers coverage through every major metropolitan market in the eastern United States. Analysts see revenue inching up by 3 percent, with CSX's profit of $0.42 a share besting the $0.40 a share it posted a year earlier. CSX will
Best Building Product Stocks To Watch Right Now: Cheetah Mobile Inc (CMCM)
Cheetah Mobile Inc., formerly Kingsoft Internet Software Holdings Limited, incorporated in July 2009, is a mobile Internet company. For its users, its diversified suite of mission critical applications optimizes Internet and mobile system performance and provides real time protection against known and unknown security threats. For its business partners, its platform provides them multiple user traffic entry points and global content distribution channels capable of delivering targeted content to hundreds of millions of people. The Company��s applications include Clean Master, CM Security, Battery Doctor, Duba Anti-virus, Cheetah Browser and Photo Grid. The Company's core platform products for business partners, such as Duba.com, Cheetah personalized recommendation engine, Game centers, Game centers and Kingmobi mobile advertising network.
The Company��s cloud-based data analytics engines are the core of its platform. For its users, the data analytics engines perform real time analysis of mobile applications, program files and Websites on their devices for behavior that may impair system performance or impose security risks. For its business partners, the data analytics engines help create user interest graphs according to a number of dimensions, such as online shopping, gaming and frequently used applications, thus facilitating targeted content delivery.
Clean Master is a junk file cleaning, memory boosting and privacy protection application. CM Security is an anti-virus and security application for mobile devices on the Android platform. Battery Doctor is a power optimization application. Duba Anti-virus is an Internet security application. Cheetah Browser is its safe Internet browser. Photo Grid is a photo collage application.
The Company competes with Qihoo 360.
Advisors' Opinion:- [By Steve Symington]
What:�Shares of Cheetah Mobile (NYSE: CMCM ) fell 16% Tuesday after the Chinese Internet security software specialist released unaudited first-quarter results.
- [By Garrett Cook]
Cheetah Mobile (NASDAQ: CMCM) rose 11 percent on news the company had its app relisted in the Google App Store ranking system. The release was published in a Chinese publication.
- [By Peter Graham]
Formerly known as Kingsoft Internet Software Holdings Limited, small cap China mobile Internet stock Cheetah Mobile Inc (NYSE: CMCM), a potential peer of other Chinese mobile Internet stocks like NQ Mobile Inc (NYSE: NQ), Qihoo 360 Technology Co Ltd (NYSE: QIHU)�and China Mobile Games and Entertainment Group Limited (NASDAQ: CMGE), is ranked as the ninth most shorted stock on the NYSE with short interest of 38.02% according to Highshortinterest.com.
Best Building Product Stocks To Watch Right Now: Mattress Firm Holding Corp (MFRM)
Mattress Firm Holding Corp. (Mattress Firm), incorporated on January 5, 2007, is a specialty retailer of mattresses and related products and accessories in the United States. The Company conducts its operations through its indirect, wholly owned subsidiary, Mattress Holding Corp. and its subsidiaries. As of August 2, 2011, the Company and its franchisees operated 620 and 107 stores, respectively, primarily under the Mattress Firm name, in 60 markets across 25 states. The Company focuses on the national brands, but also offers its customers its Hampton and Rhodes private label mattresses. The Company has introduced its YuMe brand. On October 15, 2010, the Company acquired Peak Management, LLC. On December 1, 2010, the Company acquired Maggie's Enterprises, Inc. In May 2012, Mattress Firm announced the completion of its acquisition of regional bedding company, Mattress Giant Holding Corp. Effective September 9, 2013, Mattress Firm Holding Corp, a unit of JW Childs Associates LP, acquired Olejo Inc, a provider of ecommerce retail services.
The Company��s stores carry national mattress brands, with a range of styles, sizes, price points and features. The Company provides its customers with their choice of traditional mattresses, including Sealy and Simmons, as well as specialty mattresses, such as Tempur-Pedic. In addition to its mattress selection, the Company offers a range of bedding-related products and accessories.
Conventional Mattresses
Conventional mattresses, such as those of Sealy (including Sealy Posturepedic and Stearns and Foster) and Simmons (including Simmons Beautyrest), utilize steel-coil innersprings. During the fiscal year ended February 1, 2011, the conventional mattresses represented approximately 75% of bedding industry sales in the United States and approximately 60% of the Company��s total sales. In addition to these national brands, the Company also offers its Hampton and Rhodes private label mattresses.
Specialty Mattresses
Specialty mattresses, such as those manufactured by Tempur-Pedic and select comfort, utilize materials other than steel-coil innersprings to provide comfort and support. In fiscal 2010, the specialty mattresses represented approximately 30% of the Company��s total sales. The Company is expanding its assortments in the categories, including viscoelastic foam mattresses and yume sleep system. Viscoelastic foam, also referred to as memory foam or polyurethane foam, features a temperature sensitive foam core that reduces pressure points and tossing and turning by contouring to one's body. The Company has introduced a sleep system made of foam produced from coconut oil, utilizing a technology that uses ambient air to heat and cool the mattress surface.
Furniture and Accessories
During fiscal 2010, the Company was in the process of introducing new headboards and footboards, which complement its current bedding products. All of the Company��s stores carry an assortment of bedding-related accessories, including bed frames, mattress pads and pillows. In fiscal 2010, bedding-related products and accessories represented approximately 7% of the Company��s total sales from Company-operated stores.
The Company competes with Mattress Giant, American Mattress, Haverty's, Rooms-To-Go, Macy's, Sears, JC Penney, Walmart, Costco and Original Mattress.
Advisors' Opinion:- [By John Kell]
Mattress Firm Holding Corp.(MFRM) tempered expectations for 2013, as the company said results were hurt by poor winter weather and lower margins tied to efforts to drive sales and traffic during the final quarter of the year. Shares slumped 9.9% to $37.17 premarket.
- [By Rebecca McClay]
In consumer stocks news, Mattress Firm Holding Corp. (Nasdaq: MFRM) shares are down 15% as the company reported Q2 adjusted earnings per share (EPS) of $0.43 versus consensus estimate of $0.51. Net sales were $302.5 million, compared to the $323 million the Street expected. Year-ago adjusted EPS was $0.42, on net sales of $262 million.
- [By Lisa Levin]
Mattress Firm Holding (NASDAQ: MFRM) shares reached a new 52-week high of $47.03 after the company reported upbeat Q4 earnings and raised its FY14 forecast.
Best Building Product Stocks To Watch Right Now: Lazard LTD. (LAZ)
Lazard Ltd., together with its subsidiaries, operates as a financial advisory and asset management firm. The company�s Financial Advisory segment offers various advisory services on mergers and acquisitions, and other strategic matters, as well as on restructurings, capital structure, capital raising, and other financial matters. Its Asset Management segment provides investment solutions and investment management services in equity and fixed income strategies; and alternative investments and private equity funds. The company serves corporations, governments, institutions, partnerships, and individual clients. It operates from 42 cities across 27 countries in Europe, North America, Asia, Australia, the Middle East, and Central and South Americas. Lazard Ltd. was founded in 1848 and is based in Hamilton, Bermuda.
Advisors' Opinion:- [By David Hanson and Matt Koppenheffer]
In this segment from Thursday's episode of The Motley Fool's everything-financials show,�Where the Money Is, banking analysts Matt Koppenheffer and David Hanson go through a rapid-fire round of three top headlines. The newsmakers included�KKR (NYSE: KKR ) ,�Bank of America (NYSE: BAC ) ,�Morgan Stanley (NYSE: MS ) ,�Lazard (NYSE: LAZ ) , and�Evercore (NYSE: EVR ) .
- [By Ben Levisohn]
Horowitz predicts Lazard (LAZ), which returned 55% last year, to gain just 4% in 2014 as weaker merger & acquisition activity will weight on earnings.
Best Building Product Stocks To Watch Right Now: CannaVEST Corp (CANV)
CannaVEST Corp., formerly Foreclosure Solutions, Inc., incorporated on December 9, 2010, is engaged in the business of developing, producing, marketing and selling end consumer products to the nutriceutical industry containing the hemp plant extract, Cannabidoil (CBD). The Company produces raw ingredients for neutraceutical markets. This substance can be used with foods and nutritional supplements for consumer health and wellness benefits, as well as in the pharmaceutical industry. On March 4, 2013, the Company acquired KannaLife Sciences, Inc. On December 31, 2012, the Company acquired certain assets of PhytoSPHERE Systems, LLC (PhytoSPHERE). It also secured the license to the name PhytoSPHERE and PhytoSPHERE Systems for use in the development and commercialization of hemp-based products.
The Company focuses to develop applicable raw ingredients, and provide raw ingredients for the production and development of multiple existing and developing product applications. Its focus is to produce, market and distribute hemp-based consumer products, as well as acquire existing businesses involved in the industrial hemp industries.
Advisors' Opinion:- [By John Udovich]
The Marijuana Index is Really Getting Stoned. The Marijuana Index, which is the first and only registered equity tracking index for marijuana stocks, cannabis stocks and hemp stocks,�experienced significant volume and price fluctuations throughout the month of February when is started the month at the $25 level only to close the month at $56.21 for a 125% gain as some marijuana stocks experienced all time highs. Notable gainers included Abattis Bioceuticals (OTCMKTS: ATTBF)�being up 194%, Advanced Cannabis Solutions (OTCQB: CANN) being up 132% and CannaVest (OTCMKTS: CANV) being up 116%. You can see all of the�Marijuana Index��s advancers and decliners at http://www.marijuanaindex.org.
- [By Dan Burrows]
But it doesn’t end there. Investors should run away from all OTC marijuana stocks, including Medical Marijuana (MJNA), Cannabis Science (CBIS), CannaVest (CANV), MediSwipe (MWIP) and GreenGro Technologies (GRNH). As the SEC warns:
Best Building Product Stocks To Watch Right Now: Heidrick & Struggles International Inc (HSII)
Heidrick & Struggles International, Inc. (Heidrick & Struggles) is an advisory firm providing executive search and leadership consulting services. As of December 31, 2011, the Company provided its services to a range of clients through the expertise of 347 consultants located in various cities around the world. The Company��s service offerings include executive search, leadership consulting and client base. The Company helps its clients build leadership teams by facilitating the recruitment, management and deployment of senior executives. In addition to executive search, it provides a range of leadership consulting services to clients. These services include succession planning, executive assessment, talent retention management, executive development, transition consulting for newly appointed executives, and mergers and acquisitions human capital integration consulting. In November 2013, Heidrick & Struggles International, Inc announced the acquisition of Scambler MacGregor.
The Company��s clients includes clients include Fortune 1000 companies, non-United States companies, middle market and emerging growth companies, governmental, higher education and not-for-profit organizations and other private and public entities. Heidrick & Struggles provides senior-level executive search and leadership consulting services to its clients worldwide through a network of more than 69 offices in 40 countries. The locations are staffed with consultants, research associates, administrative assistants and other support staff. Administrative functions are centralized where possible, although certain support and research functions are situated regionally because of variations in local requirements.
The Company��s worldwide network includes affiliate relationships in Finland, South Africa, Turkey and Portugal. It has no financial investment in these affiliates but receive licensing fees from them for the use of its name and its databases. Licensing fees are less than 1% of its net revenue. As ! of December 31, 2011, the Company had 160 consultants in its Americas segment, which included New York, Chicago and Atlanta. As of December 31, 2011, the Company had 104 consultants in its European segment, which included the United Kingdom, Germany and France. As of December 31, 2011, the Company had 83 consultants in itsAsia Pacific segment, which included China (including Hong Kong), Australia and Singapore. The Company��s executive search business operates in six broad industry groups: Financial Services, Industrial, Consumer Markets, Global Technology and Services, Life Sciences, and Education and Social Enterprise.
Its executive search consultants also specialize in searches for specific C-level functional positions, which are roles that generally report directly to the chief executive officer. These include chief financial officers, chief information officers, chief legal officers, chief marketing officers and chief human resources officers. The Company��s Global Functional Practices include Chief Executive Officer and Board of Directors; Chief Human Resources Officers; Financial Officers; Information Officers; Interim Executives; Legal, Risk, Compliance & Government Affairs; Marketing, Sales & Strategy Officers; Multicultural & Digital Marketing; Sales Officers; Research & Development; and Supply Chain & Transportation.
The Company competes with Egon Zehnder International, Korn/Ferry International, Russell Reynolds Associates, Inc. and Spencer Stuart & Associates.
Advisors' Opinion:- [By Anders Bylund]
And if you thought this crack team would look only at internal promotion candidates, headhunter firm Heidrick & Struggles (NASDAQ: HSII ) is there to vet the field of outsider candidates. It's a high-profile contract for Heidrick, but the stock fell 0.7% today anyhow. The lack of popping champagne corks in the company's Chicago headquarters is an indication of just how tough this recruitment drive will be.
Best Building Product Stocks To Watch Right Now: Marine Products Corp (MPX)
Marine Products Corporation (Marine Products), incorporated on August 31, 2000, designs, manufactures and sells recreational fiberglass powerboats in the sportboat, deckboat, cruiser, sport yacht and sport fishing markets. The Company sells its products to a network of 135 domestic and 69 international independent authorized dealers. The Company focuses to remain a manufacturer of recreational powerboats for sale to a range of consumers globally. The Company manufactures Chaparral sterndrive and inboard-powered pleasure boats including H2O Sport and Fish & Ski boats, SSi and SSX Sportboats, Sunesta Sportdecks and Xtreme Tow boats, Signature Cruisers, Premiere Sport Yachts and Robalo outboard sport fishing boats. The Company offers a range of products to the family recreational, cruiser and sport yacht markets through its Chaparral brand, and to the sport fishing market through its Robalo brand.
The Company's products include Chaparral - H2O Sport Series, which is a fiberglass multipurpose runabouts; Chaparral - SSi Wide tech, which is a fiberglass closed deck runabouts; Chaparral - SSX Sportdecks, which is a fiberglass bowrider crossover sportboats; Chaparral - Sunesta Xtreme Tow Boats, which is a fiberglass pleasure boats; Chaparral - Signature Cruisers, which is a fiberglass, accommodation-focused cruisers; Chaparral - Premiere Sport Yacht, which is a fiberglass sport yacht, and Robalo - Sport Fishing Boats, which is a sport fishing boats for freshwater lakes or saltwater use. Domestic sales are made through approximately 74 Chaparral dealers, 16 Robalo dealers and 45 dealers that sell both brands located in markets throughout the United States. Marine Products also has 69 international dealers.
The Company competes with Sea Hunt, Sea Fox, Grady-White, Boston Whaler, Everglades and Parker.
Advisors' Opinion:- [By Sean Williams]
Sink or swim
Sometimes the best short-sale opportunities are small, under-the-radar companies. One that I feel fits the bill perfectly is fiberglass boat maker Marine Products (NYSE: MPX ) .
